Webisodes

Health Policy Update: From the SGR Fix to 340B

Is a long-term solution for the SGR fix on the horizon? How will payer awareness of 340B potentially impact drug prices? As ongoing debate in Washington continues to hang over healthcare stakeholders, AmerisourceBergen Consulting Services President Peyton Howell returns to the program to discuss recent issues—from changing deadlines for Meaningful Use requirements, to bridge programs for uninsured Americans and drug shortages.